Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 28-day, Polysomnographic Study of Gabapentin 250 mg in Transient Insomnia Induced by a Sleep Phase Advance
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Pfizer; Viatris Inc
- 19 Aug 2008 New trial record.